Chicago-based Green Thumb, which operates cannabis cultivation, production and retail operations across 11 states, announced the closing of the Advanced Grow Labs deal on Tuesday, an $80-million acquisition involving $15 million in cash and $65 million in stock. Advanced Grow Labs operates a 41,000 sq. ft. manufacturing facility in West Haven, CT, and has a 46 per cent stake in one of nine newly issued dispensary licenses in Connecticut’s medical-only market. (All figures in US dollars unless otherwise noted.)
Stanley points out that state governor Lamont has said that adult-use legalization is a priority for his administration, while in January, House Democrats introduced a legalization bill, thus making CT ripe for “significant growth potential,” according to Stanley.
On February 5, Green Thumb announced an agreement to acquire California cannabis brand company Beboe, with Stanley now noting that luxury retailer Barneys New York has announced that its flagship store in Beverly Hills will feature an exclusive partnership with Beboe and its luxury line of vape pens, pastilles and CBD products, an event which the analyst takes as “strong validation of the brand’s luxury status and market potential.”
“We continue to view Green Thumb as a compelling investment opportunity given its strong and growing presence in attractive US states, and demonstrated success in both acquisitions (such as AGL) as well as organic growth (via de novo licensing wins in New Jersey and Pennsylvania). Potential catalysts include closing of the acquisitions in Nevada (Essence) and New York, additional licensing wins, and the Q4/18 results in April,” says Stanley.
The analyst says GTII is still trading at a 71 per cent discount to its similarly-sized peers. He is expecting the company to generate Attr. EBITDA of $62.1 million in 2019 on revenue of $229.5 million and Attr. EBITDA of $192.0 million in 2020 on a top line of $523.5 million. His C$44 target represents a projected return of 163 per cent at the time of publication.
TD Cowen analyst Vince Valentini says the recent pullback in BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE) shares… [Read More]
Roth Capital Partners analyst Craig Irwin says VersaBank’s (VBNK Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) early commercial rollout of… [Read More]
Roth Capital Partners analyst Suji Desilva says Rocket Lab USA’s (Rocket Lab USA Stock Quote, Chart, News, Analysts, Financials NASDAQ:RKLB)… [Read More]
Research Capital analyst Andre Uddin says Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) has upcoming clinical… [Read More]
Beacon Securities analyst Russell Stanley says Firan Technology Group’s (Firan Technology Group Stock Quote, Chart, News, Analysts, Financials TSX:FTG) new… [Read More]
LionGuard Capital Management CEO and CIO Andrey Omelchak says Magellan Aerospace (Magellan Aerospcace Stock Quote, Chart, News, Analysts, Financials TSX:MAL)… [Read More]